SEC Form D private-offering filing

Luminary Therapeutics, Inc.

Name: Luminary Therapeutics, Inc. - new SEC Form D private-offering filing, Minneapolis, MN
Published: 2025-11-05

A new SEC Form D private-offering notice from Minneapolis, MN, a $12,388,157 filer-stated offering target in Biotech. The source filing is one click away.

Luminary Therapeutics, Inc. site↗ Verified via SEC Form D

Developer of allogeneic CAR T cell therapies using a proprietary gamma delta platform to target solid tumors, blood cancers and autoimmune disorders.

Filed 2025-11-05Filed to raise $12,388,157First money in 2025-10-14Raised so far $1,406,112HQ (as filed) Minneapolis, MNSector Biotech ✓Stage (inferred) EarlyCall status Delayed filing

Source linked the Form D on EDGAR↗Website verified luminarytx.com↗Named in the filing 7 executives & directors

Open this row on the live feed →More new filings in Minnesota →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.